140 related articles for article (PubMed ID: 34699290)
1. A more frequent disease monitorering but no increased disease activity in patients with inflammatory bowel disease during the first year of the SARS-CoV-2 pandemic. A retrospective study.
Lindhagen S; Karling P
Scand J Gastroenterol; 2022 Feb; 57(2):169-174. PubMed ID: 34699290
[TBL] [Abstract][Full Text] [Related]
2. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
Moum KM; Moum B; Opheim R
Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, Efficiency, and Acceptability of Telemedicine for Inflammatory Bowel Disease Patients' Follow-Up Care during the COVID-19 Pandemic.
Ramos L; Reygosa C; Carrillo-Palau M; Alonso-Abreu I; González-Mendez Y; de la Barreda R; Amaral C; Hernández A; Benítez-Zafra F; Hernandez-Guerra M
Dig Dis; 2023; 41(4):574-580. PubMed ID: 36716727
[TBL] [Abstract][Full Text] [Related]
4. Expanding telehealth options during the COVID pandemic eliminated racial and age disparities in electronic communication by inflammatory bowel disease patients.
Hayrapetian L; Zepp M; Rao S; Hennessey M; Houle M; Atienza M; Belfaqeeh OA; Dharia I; Khan A; Borum ML
J Natl Med Assoc; 2021 Aug; 113(4):474-477. PubMed ID: 33941370
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
Bekic D; Belosic Halle Z
Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
[TBL] [Abstract][Full Text] [Related]
6. Telehealth model of care for outpatient inflammatory bowel disease care in the setting of the COVID-19 pandemic.
Shah R; Wright E; Tambakis G; Holmes J; Thompson A; Connell W; Lust M; Niewiadomski O; Kamm M; Basnayake C; Ding J
Intern Med J; 2021 Jul; 51(7):1038-1042. PubMed ID: 34278693
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves.
Bezzio C; Vernero M; Costa S; Armuzzi A; Fiorino G; Ardizzone S; Roselli J; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Alimenti E; Balestrieri P; Ricci C; Cappello M; Felice C; Coppini F; Alvisi P; Di Luna I; Gerardi V; Variola A; Mazzuoli S; Lenti MV; Saibeni S;
BMC Gastroenterol; 2023 Jul; 23(1):230. PubMed ID: 37407913
[TBL] [Abstract][Full Text] [Related]
8. A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.
Di Ruscio M; Lunardi G; Buonfrate D; Gobbi F; Bertoli G; Piccoli D; Conti A; Geccherle A; Variola A
Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684085
[No Abstract] [Full Text] [Related]
9. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
[TBL] [Abstract][Full Text] [Related]
10. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Bowel Disease and COVID-19: How Have Patients Coped So Far?
Schlabitz F; Teich N; Riesner-Wehner A; Böhm S; Greinert R; Eisenmann S; Michl P; Walldorf J
J Clin Gastroenterol; 2022 Feb; 56(2):e126-e130. PubMed ID: 33538442
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
Ng SC; Mak JWY; Hitz L; Chowers Y; Bernstein CN; Silverberg MS
J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S791-S797. PubMed ID: 33085973
[TBL] [Abstract][Full Text] [Related]
13. Comparison of satisfaction degree of patients treated at the Inflammatory Bowel Disease Unit (IBDU) of Hospital Universitario 12 de Octubre between previous face-to-face care and telephone care during the COVID-19 pandemic.
Vázquez García P; Fernández-Gordón Sánchez FM; Algara San Nicolás M; Yela San Bernardino C; Casis Herce B; Masedo González Á; Gómez Gómez GJ; Martínez Montiel MDP
Rev Esp Enferm Dig; 2022 Jan; 114(1):58-59. PubMed ID: 34517711
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic.
Vadan R; Iacob R; Costache R; Stroie T; Saizu IA; Iacob S; Gheorghe L; Diculescu M; Gheorghe C
J Gastrointestin Liver Dis; 2020 Dec; 29(4):549-553. PubMed ID: 33331349
[TBL] [Abstract][Full Text] [Related]
15. Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?
Del Hoyo J; Millán M; Garrido-Marín A; Nos P; Barreiro-de Acosta M; Bujanda L; de la Portilla F; Aguas M;
Gastroenterol Hepatol; 2022 Nov; 45(9):697-705. PubMed ID: 34508808
[TBL] [Abstract][Full Text] [Related]
16. Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures.
Taxonera C; Alba C; Olivares D; Martin M; Ventero A; Cañas M
Inflamm Bowel Dis; 2021 May; 27(6):864-869. PubMed ID: 32812035
[TBL] [Abstract][Full Text] [Related]
17. Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease.
Khan N; Mahmud N; Patel M; Sundararajan R; Reinisch W
Aliment Pharmacol Ther; 2023 Apr; 57(7):800-807. PubMed ID: 36645110
[TBL] [Abstract][Full Text] [Related]
18. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.
Nakase H; Wagatsuma K; Nojima M; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Takeuchi K; Tamura S; Kinjo F; Ueno N; Naganuma M; Watanabe K; Moroi R; Nishimata N; Motoya S; Kurahara K; Takahashi S; Maemoto A; Sakuraba H; Saruta M; Tominaga K; Hisabe T; Tanaka H; Terai S; Hiraoka S; Takedomi H; Narimatsu K; Endo K; Nakamura M; Hisamatsu T
J Gastroenterol; 2023 Mar; 58(3):205-216. PubMed ID: 36607399
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
Yang Z; Clark N; Park KT
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
[TBL] [Abstract][Full Text] [Related]
20. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic.
Goodsall TM; Han S; Bryant RV
J Gastroenterol Hepatol; 2021 Jun; 36(6):1550-1555. PubMed ID: 33063927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
